2021-2022 Vaccine Recomendations

Generic Lab Tubes and Plates

2021-2022 WHO Northern Hemisphere recommendations

26 February 2021

It is recommended that quadrivalent vaccines for use in the 2021-2022 influenza season (Northern Hemisphere winter) contain the following:

Egg based vaccines:

  • an A/Victoria/2570/2019 (H1N1)pdm09-like virus
  • an A/Cambodia/e0826360/2020 (H3N2)-like virus;
  • a B/Washington/02/2019 (B/Victoria lineage)-like virus; and
  • a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus.

    • Cell or recombinant based vaccines:

  • an A/Wisconsin/588/2019 (H1N1)pdm09-like virus;
  • an A/Cambodia/e0826360/2020 (H3N2)-like virus;
  • a B/Washington/02/2019 (B/Victoria lineage)-like virus; and
  • a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus.

    • It is recommended that trivalent vaccines for use in the 2021-2022 influenza season (Northern Hemisphere winter) contain the following:

    Egg based vaccines:

  • an A/Victoria/2570/2019 (H1N1)pdm09-like virus
  • an A/Cambodia/e0826360/2020 (H3N2)-like virus; and
  • a B/Washington/02/2019 (B/Victoria lineage)-like virus

    • Cell or recombinant based vaccines:

  • an A/Wisconsin/588/2019 (H1N1)pdm09-like virus;
  • an A/Cambodia/e0826360/2020 (H3N2)-like virus; and
  • a B/Washington/02/2019 (B/Victoria lineage)-like virus.

    • Full WHO Recommendation

    Top of Page

    AIVC recommendation for the composition of influenza vaccine for Australia in 2021

    9 October 2020

    The AIVC met on 7 October 2020 and recommended that the following viruses be used for influenza vaccines in the 2021 Southern Hemisphere influenza season:

    Egg based vaccines:

  • an A/Victoria/2570/2019 (H1N1)pdm09-like virus
  • an A/Hong Kong/2671/2019 (H3N2)-like virus;
  • a B/Washington/02/2019 (B/Victoria lineage)-like virus; and
  • a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus.

    • Cell or recombinant based vaccines:

  • an A/Wisconsin/588/2019 (H1N1)pdm09-like virus;
  • an A/Hong Kong/45/2019 (H3N2)-like virus;
  • a B/Washington/02/2019 (B/Victoria lineage)-like virus; and
  • a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus.

    • See the TGA website for further information

    Top of Page

    2021 WHO Southern Hemisphere recommendations

    25 September 2020

    It is recommended that quadrivalent vaccines for use in the 2021 influenza season (Southern Hemisphere winter) contain the following:

    Egg based vaccines:

  • an A/Victoria/2570/2019 (H1N1)pdm09-like virus
  • an A/Hong Kong/2671/2019 (H3N2)-like virus;
  • a B/Washington/02/2019 (B/Victoria lineage)-like virus; and
  • a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus.

    • Cell or recombinant based vaccines:

  • an A/Wisconsin/588/2019 (H1N1)pdm09-like virus;
  • an A/Hong Kong/45/2019 (H3N2)-like virus;
  • a B/Washington/02/2019 (B/Victoria lineage)-like virus; and
  • a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus.

    • It is recommended that trivalent vaccines for use in the 2021 influenza season (Southern Hemisphere winter) contain the following:

    Egg based vaccines:

  • an A/Victoria/2570/2019 (H1N1)pdm09-like virus
  • an A/Hong Kong/2671/2019 (H3N2)-like virus; and
  • a B/Washington/02/2019 (B/Victoria lineage)-like virus

    • Cell or recombinant based vaccines:

  • an A/Wisconsin/588/2019 (H1N1)pdm09-like virus;
  • an A/Hong Kong/45/2019 (H3N2)-like virus; and
  • a B/Washington/02/2019 (B/Victoria lineage)-like virus.

    • Full WHO Recommendation

    Top of Page

    To view Recommendations from previous years, please click below: